[EFFECTS OF SYNTHETIC LYSL-8-VASOPRESSIN ON ADRENALINE-CHLOROFORM ARRHYTHMIAS IN THE ANESTHETIZED DOG].
D000889:Anti-Arrhythmia Agents; D001127:Arginine Vasopressin; D001145:Arrhythmias, Cardiac; D001794:Blood Pressure; D002725:Chloroform; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine; D010455:Peptides; D010600:Pharmacology; D011802:Quinidine; D012106:Research; D014116:Toxicology; D014667:Vasopressins; D014693:Ventricular Fibrillation
D000889:Anti-Arrhythmia Agents; D010455:Peptides; D014667:Vasopressins; D001127:Arginine Vasopressin; D002725:Chloroform; D011802:Quinidine; D004837:Epinephrine
ARRHYTHMIA; BLOOD PRESSURE; CHLOROFORM; DOGS; ELECTROCARDIOGRAPHY; EPINEPHRINE; EXPERIMENTAL LAB STUDY; MYOCARDIAL DEPRESSANTS; PEPTIDES; PHARMACOLOGY; QUINIDINE; TOXICOLOGIC REPORT; VASOPRESSIN; VENTRICULAR FIBRILLATION
EFFETS DE LA LYSYL 8-VASOPRESSINE SYNTH'ETIQUE SUR LES ARYTHMIES ADR'ENALINO-CHLOROFORMIQUES CHEZ LE CHIEN ANESTH'ESI'E.